![Axon Neuroscience initiates Phase II trial of tau vaccine AADvac1 to treat Alzheimer's disease - Clinical Trials Arena Axon Neuroscience initiates Phase II trial of tau vaccine AADvac1 to treat Alzheimer's disease - Clinical Trials Arena](https://www.drugdevelopment-technology.com/wp-content/uploads/image-digitalinsightresearch/nri/Drug%20development/News/June%202016/Alzheimer%2023%20June.jpg)
Axon Neuroscience initiates Phase II trial of tau vaccine AADvac1 to treat Alzheimer's disease - Clinical Trials Arena
![PDF) A randomized controlled trial comparing in-person and wiki-inspired nominal group techniques for engaging stakeholders in chronic kidney disease research prioritization PDF) A randomized controlled trial comparing in-person and wiki-inspired nominal group techniques for engaging stakeholders in chronic kidney disease research prioritization](https://i1.rgstatic.net/publication/307567032_A_randomized_controlled_trial_comparing_in-person_and_wiki-inspired_nominal_group_techniques_for_engaging_stakeholders_in_chronic_kidney_disease_research_prioritization/links/57d06e0508ae5f03b4890eba/largepreview.png)
PDF) A randomized controlled trial comparing in-person and wiki-inspired nominal group techniques for engaging stakeholders in chronic kidney disease research prioritization
![DIAGNOSIS AND MANAGEMENT OF ATYPICAL PARKINSONIAN SYNDROMES | Journal of Neurology, Neurosurgery & Psychiatry DIAGNOSIS AND MANAGEMENT OF ATYPICAL PARKINSONIAN SYNDROMES | Journal of Neurology, Neurosurgery & Psychiatry](https://jnnp.bmj.com/content/jnnp/72/suppl_1/i10/F4.medium.gif)